Treatment of pediatric hypertension

被引:17
作者
Temple, ME
Nahata, MC
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
[3] Childrens Hosp, Columbus, OH 43205 USA
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 02期
关键词
D O I
10.1592/phco.20.3.140.34782
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We conducted a MEDLINE search from January 1966-March 1999 to obtain information on clinical trials of treatment of pediatric hypertension. An article was selected for review if it described a randomized or nonrandomized study; randomized studies were given priority. Case reports were considered when studies were unavailable. Review articles were useful in identifying references. According to data we collected, hypertension is present in 1-3% of the pediatric population Nonpharmacologic treatment may be effective initially in those with mild to moderate disease or as an adjunct to drug therapy. Drugs for treatment of chronic hypertension include calcium channel blockers, angiotensin-converting enzyme inhibitors, diuretics, and beta-blockers. Patient and drug characteristics determine therapy. Intravenous labetalol, nicardipine, and nitroprusside are effective for treating hypertensive emergencies.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 69 条
[31]  
LARSON A, 1994, CLIN PEDIATR, V25, P309
[32]   PEDIATRIC HYPERTENSION - CLINICAL PERSPECTIVE [J].
LIEBERMAN, E .
MAYO CLINIC PROCEEDINGS, 1994, 69 (11) :1098-1107
[33]   HYPERTENSION IN APPARENTLY NORMAL CHILDREN [J].
LONDE, S ;
BOURGOIGNIE, JJ ;
ROBSON, AM ;
GOLDRING, D .
JOURNAL OF PEDIATRICS, 1971, 78 (04) :569-+
[34]   TREATMENT OF HYPERTENSIVE CRISIS IN CHILDREN WITH NIFEDIPINE [J].
LOPEZHERCE, J ;
ALBAJARA, L ;
CAGIGAS, P ;
GARCIA, S ;
RUZA, F .
INTENSIVE CARE MEDICINE, 1988, 14 (05) :519-521
[35]   STABILITY OF ISRADIPINE IN AN EXTEMPORANEOUSLY COMPOUNDED ORAL LIQUID [J].
MACDONALD, JL ;
JOHNSON, CE ;
JACOBSON, P .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (19) :2409-2411
[36]   Nicardipine for hypertensive emergencies in children with renal disease [J].
Michael, J ;
Groshong, T ;
Tobias, JD .
PEDIATRIC NEPHROLOGY, 1998, 12 (01) :40-42
[37]   PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION IN PEDIATRIC-PATIENTS - A COMPREHENSIVE REVIEW OF THE EFFICACY, SAFETY AND DOSAGE GUIDELINES OF THE AVAILABLE AGENTS [J].
MILLER, K .
DRUGS, 1994, 48 (06) :868-887
[38]  
MILLER K, 1987, Journal of Cardiovascular Pharmacology, V10, pS154
[39]  
MILLER TR, 1995, PEDIATRICS, V96, P1
[40]  
MIRKIN BL, 1985, PEDIATRICS, V75, P1091